Clinical Effect Observation of Spironolactone Combined with Benazepri in Treatment of 47 Cases with Chronic Congestive Heart Failure
Wang Lin-hu
Abstract
Wang Lin-hu
Abstract
Objective To explore the clinical effect of spironolactone combined with benazepri in treatment of chronic congestive heart failure. Methods 94 patients with chronic congestive heart failure in our hospital were randomly divided into spironolactone combined with benazepri treatment group(observation group) and benazepri treatment group(control group), 47 cases in each group, compared the clinical effect of patients in two groups. Results The total effective rate of patients in observation group was 91.5%, significantly higher than that in control group(74.5%), there was significant difference between two groups(P0.05). There were no obvious adverse reactions during treatment. Conclusion Taking spironolactone combined with benazepri in the treatment of chronic congestive heart failure has effective clinical effect, worthy of further clinical application.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To explore the clinical effect of spironolactone combined with benazepri in treatment of chronic congestive heart failure. Methods 94 patients with chronic congestive heart failure in our hospital were randomly divided into spironolactone combined with benazepri treatment group(observation group) and benazepri treatment group(control group), 47 cases in each group, compared the clinical effect of patients in two groups. Results The total effective rate of patients in observation group was 91.5%, significantly higher than that in control group(74.5%), there was significant difference between two groups(P0.05). There were no obvious adverse reactions during treatment. Conclusion Taking spironolactone combined with benazepri in the treatment of chronic congestive heart failure has effective clinical effect, worthy of further clinical application.
Key concepts: Spironolactone, Medicine, Heart failure, Internal medicine, Clinical efficacy, Significant difference, Treatment and control groups, Cardiology